IP Library Granted Patent US 8,380,294
Granted Patent B2
US 8,380,294 · App. 12/765,482 · Granted Feb 19, 2013

Cardiac risk stratification

Inventors: Marc D. Messier (Bombaye, BE); Daniel Becker (Heerlen, NL); Raphael Schneider (Maastricht, NL)
Assignee: Medtronic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,380,294
App. No.
12/765,482
Granted
Feb 19, 2013
Kind
B2
Abstract

This disclosure describes techniques for generating a risk stratification indicator based on HRT measurements computed using physiological parameters sensed by an implantable medical device (IMD). In some examples, the HRT measurements may be computed by the IMD based on the physiological parameters. In other examples, the IMD may sense the physiological parameters, and transmit data representative of the parameters to an external computing device, such as an IMD programmer, which then computes the HRT measurements. Exemplary physiological parameters include cardiac signals.

Claims (50)

1. A method comprising:

determining, by one or more processors and based on physiological parameters of a patient obtained by an implantable medical device, a first heart rate turbulence (HRT) slope at a first time after an occurrence of a myocardial infarction and a second HRT slope at a second time after the occurrence of the myocardial infarction;

calculating, by the one or more processors, a difference value between the first HRT slope and the second HRT slope; and

determining, by the one or more processors, a level of recovery of autonomic function between the first time and the second time based on the calculated difference.

2. The method of claim 1 , wherein the first time is approximately one week after the occurrence of the myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of the myocardial infarction.

3. The method of claim 1 , further comprising:

comparing the difference value to a threshold value of about 2 milliseconds per R-R interval, wherein determining a level of recovery comprises determining the level of recovery based on the comparison.

4. The method of claim 3 , wherein determining the level of recovery of autonomic function based on the calculation comprises:

determining the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determining the level of recovery to be in a second category if the difference value is less than the threshold value.

5. The method of claim 4 , further comprising:

generating a risk stratification indicator if the level of recovery is determined to be in the second category.

6. The method of claim 5 , wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.

7. The method of claim 1 , further comprising:

delivering, when no intrinsic abnormal heartbeats are occurring, electrical stimulation at a first time in order to induce a plurality of abnormal heartbeats at the first time; and

delivering, when no intrinsic abnormal heartbeats are occurring, electrical stimulation at a second time in order to induce abnormal heartbeats at the second time,

wherein determining, from physiological parameters of a patient, a first heart rate turbulence (HRT) slope at a first time and a second HRT slope at a second time comprises determining the first HRT slope from the abnormal heartbeats induced at the first time and determining the second HRT slope from the abnormal heartbeats induced at the second time.

8. An implantable medical device (IMD) comprising:

a measurement unit configured to obtain physiological parameters for a patient; and

a processor configured to:

determine, from the physiological parameters, a first heart rate turbulence (HRT) slope at a first time after an occurrence of a myocardial infarction and a second HRT slope at a second time after the occurrence of the myocardial infarction;

calculate a difference value between the first HRT slope and the second HRT slope; and

determine a level of recovery of autonomic function based on the calculated difference.

9. The IMD of claim 8 , wherein the first time is approximately one week after the occurrence of the myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of the myocardial infarction.

10. The IMD of claim 8 , wherein the processor is further configured to:

compare the difference value to a threshold value of about 2 milliseconds per R-R interval, and wherein the processor configured to determine a level of recovery is further configured to determine the level of recovery based on the comparison.

11. The IMD of claim 10 , wherein the processor configured to determine the level of recovery of autonomic function based on the calculation is further configured to:

determine the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determine the level of recovery to be in a second category if the difference value is less than the threshold value.

12. The IMD of claim 11 , wherein the processor is further configured to:

generate a risk stratification indicator if the level of recovery is determined to be in the second category.

13. The IMD of claim 12 , further comprising:

transmitting the risk stratification indicator from the IMD to another device.

14. The IMD of claim 13 , wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.

15. A system comprising:

an implantable medical device (IMD) configured to obtain physiological parameters for a patient; and

an external computing device configured to:

receive the physiological parameters;

determine, from the physiological parameters, a first heart rate turbulence (HRT) slope at a first time after an occurrence of a myocardial infarction and a second HRT slope at a second time after the occurrence of the myocardial infarction;

calculate a difference value between the first HRT slope and the second HRT slope; and

determine a level of recovery of autonomic function based on the calculated difference.

16. The system of claim 15 , wherein the first time is approximately one week after the occurrence of the myocardial infarction, and wherein the second time is approximately six weeks after the occurrence of the myocardial infarction.

17. The system of claim 15 , wherein the external computing device is further configured to:

compare the difference value to a threshold value of about 2 milliseconds per R-R interval, and wherein the external computing device is further configured to determine a level of recovery is further configured to determine the level of recovery based on the comparison.

18. The system of claim 17 , wherein the external computing device configured to determine the level of recovery of autonomic function based on the calculation is further configured to:

determine the level of recovery to be in a first category if the difference value is equal to or greater than the threshold value; and

determine the level of recovery to be in a second category if the difference value is less than the threshold value.

19. The system of claim 18 , wherein the external computing device is further configured to:

generate a risk stratification indicator if the level of recovery is determined to be in the second category.

20. The system of claim 19 , wherein the risk stratification indicator indicates at least one of that the patient should be hospitalized, that the patient should be fitted with an implantable therapy device configured to deliver therapy, and that therapy delivered to the patient should be modified.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: MESSIER, MARC D; BECKER, DANIEL; SCHNEIDER, RAPHAEL
To: MEDTRONIC, INC.
Reel/Frame 024274/0321 →
Continuity (2)
Provisional Application 61249138 · Oct 6, 2009
Related Publication 20110082378A1 · Apr 7, 2011